Published in J Neurochem on December 02, 2010
Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism. Sci Transl Med (2012) 2.70
Disruption of social approach by MK-801, amphetamine, and fluoxetine in adolescent C57BL/6J mice. Neurotoxicol Teratol (2012) 2.12
Differences in BTBR T+ tf/J and C57BL/6J mice on probabilistic reversal learning and stereotyped behaviors. Behav Brain Res (2011) 1.29
Histopathologic characterization of the BTBR mouse model of autistic-like behavior reveals selective changes in neurodevelopmental proteins and adult hippocampal neurogenesis. Mol Autism (2011) 1.11
Mice genetically depleted of brain serotonin display social impairments, communication deficits and repetitive behaviors: possible relevance to autism. PLoS One (2012) 1.10
The BTBR T+ tf/J mouse model for autism spectrum disorders-in search of biomarkers. Behav Brain Res (2012) 1.04
AMPAKINE enhancement of social interaction in the BTBR mouse model of autism. Neuropharmacology (2012) 1.04
Npas4: a neuronal transcription factor with a key role in social and cognitive functions relevant to developmental disorders. PLoS One (2012) 1.03
The serotonin system in autism spectrum disorder: From biomarker to animal models. Neuroscience (2015) 0.99
Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics. Curr Top Behav Neurosci (2016) 0.97
GABAB Receptor Agonist R-Baclofen Reverses Social Deficits and Reduces Repetitive Behavior in Two Mouse Models of Autism. Neuropsychopharmacology (2015) 0.97
Prosocial effects of oxytocin in two mouse models of autism spectrum disorders. Neuropharmacology (2013) 0.94
Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.87
Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf/J mice. Autism Res (2014) 0.87
Neonatal citalopram exposure decreases serotonergic fiber density in the olfactory bulb of male but not female adult rats. Front Cell Neurosci (2013) 0.86
Protocadherin α (PCDHA) as a novel susceptibility gene for autism. J Psychiatry Neurosci (2013) 0.86
Antidepressant-like drug effects in juvenile and adolescent mice in the tail suspension test: Relationship with hippocampal serotonin and norepinephrine transporter expression and function. Front Pharmacol (2013) 0.85
BTBR T+tf/J mice: autism-relevant behaviors and reduced fractone-associated heparan sulfate. Neurosci Biobehav Rev (2011) 0.84
Visual social preferences of lone zebrafish in a novel environment: strain and anxiolytic effects. Genes Brain Behav (2012) 0.84
Oxotremorine treatment reduces repetitive behaviors in BTBR T+ tf/J mice. Front Synaptic Neurosci (2014) 0.83
Using mouse models of autism spectrum disorders to study the neurotoxicology of gene-environment interactions. Neurotoxicol Teratol (2012) 0.83
Acute dietary tryptophan manipulation differentially alters social behavior, brain serotonin and plasma corticosterone in three inbred mouse strains. Neuropharmacology (2014) 0.82
Prenatal exposure to a common organophosphate insecticide delays motor development in a mouse model of idiopathic autism. PLoS One (2015) 0.80
Enhanced novelty-induced corticosterone spike and upregulated serotonin 5-HT1A and cannabinoid CB1 receptors in adolescent BTBR mice. Psychoneuroendocrinology (2013) 0.80
The aggression and behavioral abnormalities associated with monoamine oxidase A deficiency are rescued by acute inhibition of serotonin reuptake. J Psychiatr Res (2014) 0.79
Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environments. Aquat Toxicol (2013) 0.79
Cortical Structure Alterations and Social Behavior Impairment in p50-Deficient Mice. Cereb Cortex (2016) 0.78
Autism-associated gene Dlgap2 mutant mice demonstrate exacerbated aggressive behaviors and orbitofrontal cortex deficits. Mol Autism (2014) 0.78
Reduced sulfate plasma concentrations in the BTBR T+tf/J mouse model of autism. Physiol Behav (2012) 0.78
Serotonin neuron abnormalities in the BTBR mouse model of autism. Autism Res (2016) 0.78
Letting a typical mouse judge whether mouse social interactions are atypical. Autism Res (2013) 0.77
Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism. Psychopharmacology (Berl) (2015) 0.77
Aggression-reducing effects of F15599, a novel selective 5-HT1A receptor agonist, after microinjection into the ventral orbital prefrontal cortex, but not in infralimbic cortex in male mice. Psychopharmacology (Berl) (2013) 0.77
Effect of social odor context on the emission of isolation-induced ultrasonic vocalizations in the BTBR T+tf/J mouse model for autism. Front Neurosci (2015) 0.77
Homozygous Deletion of Glutathione Peroxidase 1 and Aldehyde Dehydrogenase 1a1 Genes Is Not Associated with Schizophrenia-Like Behavior in Mice. J Biochem Pharmacol Res (2013) 0.77
Therapeutic Effect of a Synthetic RORα/γ Agonist in an Animal Model of Autism. ACS Chem Neurosci (2015) 0.76
Transgenerational disruption of functional 5-HT1AR-induced connectivity in the adult mouse brain by traumatic stress in early life. Mol Psychiatry (2016) 0.76
5HT2A receptor blockade in dorsomedial striatum reduces repetitive behaviors in BTBR mice. Genes Brain Behav (2016) 0.75
Reversal of social deficits by subchronic oxytocin in two autism mouse models. Neuropharmacology (2015) 0.75
The BTBR mouse model of idiopathic autism - Current view on mechanisms. Neurosci Biobehav Rev (2017) 0.75
Tspyl2 Loss-of-Function Causes Neurodevelopmental Brain and Behavior Abnormalities in Mice. Behav Genet (2016) 0.75
Altered Cav1.2 function in the Timothy Syndrome mouse model produces ascending serotonergic abnormalities. Eur J Neurosci (2017) 0.75
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (2003) 28.61
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04
Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med (2008) 11.44
Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav (2004) 5.15
Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain. Cell (2007) 4.76
Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav Brain Res (2006) 4.15
An efficient SNP system for mouse genome scanning and elucidating strain relationships. Genome Res (2004) 3.96
Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav (2007) 3.76
Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav (2004) 3.69
The DISC locus in psychiatric illness. Mol Psychiatry (2007) 3.46
Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology (2004) 3.17
Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol (2007) 3.05
Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects. Hum Genet (1997) 2.88
Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology (Berl) (2009) 2.76
5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron (2010) 2.75
A review of 25 years of the social interaction test. Eur J Pharmacol (2003) 2.74
The neurobiology of autism. Brain Pathol (2007) 2.63
Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet (2005) 2.44
Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology (2009) 2.10
Assessing autism-like behavior in mice: variations in social interactions among inbred strains. Behav Brain Res (2006) 2.08
Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J Autism Dev Disord (2001) 1.98
Social approach in genetically engineered mouse lines relevant to autism. Genes Brain Behav (2008) 1.94
Serotonin and dopamine transporter binding in children with autism determined by SPECT. Dev Med Child Neurol (2008) 1.83
Social deficits in BTBR T+tf/J mice are unchanged by cross-fostering with C57BL/6J mothers. Int J Dev Neurosci (2007) 1.74
Survey of 21 inbred mouse strains in two laboratories reveals that BTBR T/+ tf/tf has severely reduced hippocampal commissure and absent corpus callosum. Brain Res (2003) 1.68
Autism and the serotonin transporter: the long and short of it. Mol Psychiatry (2005) 1.62
Postnatal lesion evidence against a primary role for the corpus callosum in mouse sociability. Eur J Neurosci (2009) 1.55
Social approach behaviors are similar on conventional versus reverse lighting cycles, and in replications across cohorts, in BTBR T+ tf/J, C57BL/6J, and vasopressin receptor 1B mutant mice. Front Behav Neurosci (2007) 1.54
Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry (2010) 1.53
5-HTTLPR Genotype-Specific Phenotype in Children and Adolescents With Autism. Am J Psychiatry (2006) 1.49
Differential effects of prenatal and postnatal expressions of mutant human DISC1 on neurobehavioral phenotypes in transgenic mice: evidence for neurodevelopmental origin of major psychiatric disorders. Mol Psychiatry (2010) 1.49
Mouse models of autism spectrum disorders: the challenge for behavioral genetics. Am J Med Genet C Semin Med Genet (2006) 1.46
Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences. J Neurosci (2000) 1.46
The development of a highly informative mouse Simple Sequence Length Polymorphism (SSLP) marker set and construction of a mouse family tree using parsimony analysis. Genome Res (2003) 1.44
Unfaithful neurotransmitter transporters: focus on serotonin uptake and implications for antidepressant efficacy. Pharmacol Ther (2008) 1.44
Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism? Int J Dev Neurosci (2005) 1.42
Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology (2002) 1.39
Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil (2005) 1.38
Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypes. Proc Natl Acad Sci U S A (2009) 1.38
Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test. Psychopharmacology (Berl) (2005) 1.37
Social deficits, stereotypy and early emergence of repetitive behavior in the C58/J inbred mouse strain. Behav Brain Res (2009) 1.27
Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: implications for differential drug effects on juveniles and adults. Biochem Pharmacol (2007) 1.27
What is known about autism: genes, brain, and behavior. Am J Pharmacogenomics (2005) 1.26
Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int J Dev Neurosci (2005) 1.26
Exaggerated responses to stress in the BTBR T+tf/J mouse: an unusual behavioral phenotype. Behav Brain Res (2008) 1.17
Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine. J Pharmacol Exp Ther (1987) 1.16
Deletion polymorphism of Disc1 is common to all 129 mouse substrains: implications for gene-targeting studies of brain function. Genetics (2006) 1.15
Modeling early cortical serotonergic deficits in autism. Behav Brain Res (2006) 1.14
Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism. Pharmacol Biochem Behav (2010) 1.10
Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology (2002) 1.08
Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice. J Neurochem (2003) 1.07
A comparison of the behavior of C57BL/6 and C57BL/10 mice. Behav Brain Res (2007) 1.07
Brain region-specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knockout mice. J Neurochem (2003) 1.07
Increased vulnerability to psychosocial stress in heterozygous serotonin transporter knockout mice. Dis Model Mech (2010) 1.07
Regulation of serotonin-1A receptor function in inducible brain-derived neurotrophic factor knockout mice after administration of corticosterone. Biol Psychiatry (2007) 1.07
Impaired fear memory, altered object memory and modified hippocampal synaptic plasticity in split-brain mice. Brain Res (2008) 1.06
Role of altered brain serotonin mechanisms in autism. Mol Psychiatry (2002) 1.06
Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders. Genes Brain Behav (2003) 1.05
Low sociability is associated with reduced size of the corpus callosum in the BALB/cJ inbred mouse strain. Brain Res (2008) 1.05
Social cognition in individuals with agenesis of the corpus callosum. Soc Neurosci (2010) 1.02
The hyperserotonemia of autism. Ann N Y Acad Sci (1990) 1.01
Modulation of behavioural profile and stress response by 5-HTT genotype and social experience in adulthood. Behav Brain Res (2009) 1.00
Corticosteroid and neurosteroid dysregulation in an animal model of autism, BTBR mice. Physiol Behav (2010) 0.99
Localization of two new X-linked quantitative trait loci controlling corpus callosum size in the mouse. Genes Brain Behav (2006) 0.98
Transmission disequilibrium studies of the serotonin 5-HT2A receptor gene (HTR2A) in autism. Am J Med Genet (2002) 0.97
Serotonin transporter expression in rat brain regions and blood platelets: aging and glucocorticoid effects. Biol Psychiatry (1997) 0.97
Reduced availability of brain amines during critical phases of postnatal development in a genetic mouse model of cognitive delay. Brain Res (2008) 0.93
Three autism candidate genes: a synthesis of human genetic analysis with other disciplines. Int J Dev Neurosci (2005) 0.93
Effects of antipsychotics and reference monoaminergic ligands on marble burying behavior in mice. Behav Pharmacol (2008) 0.92
Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders. Curr Neuropharmacol (2011) 0.92
Neurochemistry and neurophysiology of buspirone and gepirone: interactions at presynaptic and postsynaptic 5-HT1A receptors. J Clin Psychopharmacol (1990) 0.91
Modeling rare gene variation to gain insight into the oldest biomarker in autism: construction of the serotonin transporter Gly56Ala knock-in mouse. J Neurodev Disord (2009) 0.90
Clinical effect of buspirone in autistic children. J Clin Psychopharmacol (1989) 0.89
Ethnic differences in the serotonin transporter polymorphism (5-HTTLPR) in several European populations. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.89
Species-scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high-affinity recognition of antidepressants. J Neurochem (2001) 0.89
Family-based association study of 5-HTTLPR and the 5-HT2A receptor gene polymorphisms with autism spectrum disorder in Korean trios. Brain Res (2007) 0.89
Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT). Br J Pharmacol (2010) 0.87
Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.87
Quantitative autoradiography of serotonin uptake sites in rat brain using [3H]cyanoimipramine. Brain Res (1988) 0.87
Quantitative film autoradiography for tritium: methodological considerations. Brain Res (1985) 0.87
Developmental effects of SSRIs: lessons learned from animal studies. Int J Dev Neurosci (2007) 0.86
Pharmacologic treatment for the core deficits and associated symptoms of autism in children. J Pediatr Health Care (2009) 0.86
HTR1B and HTR2C in autism spectrum disorders in Brazilian families. Brain Res (2008) 0.85
Social processing deficits in agenesis of the corpus callosum: narratives from the Thematic Appreciation Test. Arch Clin Neuropsychol (2004) 0.85
C57BL/6J mice fail to exhibit preference for social novelty in the three-chamber apparatus. Behav Brain Res (2010) 0.85
Serotonin-1A receptor function in the dorsal raphe nucleus following chronic administration of the selective serotonin reuptake inhibitor sertraline. J Neurochem (2007) 0.85
Serotonin transporter genotype and neuroanatomy in autism spectrum disorders. Psychiatr Genet (2009) 0.85
Combined effect of maternal serotonin transporter genotype and prenatal stress in modulating offspring social interaction in mice. Int J Dev Neurosci (2010) 0.83
Convergent control of serotonin transporter expression by glucocorticoids and cocaine in fetal and neonatal rat brain. Brain Res Dev Brain Res (1997) 0.81
Effects of corticosterone ingestion on hippocampal [(3)H]serotonin reuptake in inbred rat strains. Endocr Regul (2001) 0.79
Corticosterone regulation of serotonin transporter and 5-HT1A receptor expression in the aging brain. Synapse (1999) 0.79
Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model. Neuropharmacology (2007) 0.79
Emerging structure-function relationships defining monoamine NSS transporter substrate and ligand affinity. Biochem Pharmacol (2009) 0.78
Perospirone, a novel antipsychotic drug, inhibits marble-burying behavior via 5-HT1A receptor in mice: implications for obsessive-compulsive disorder. J Pharmacol Sci (2005) 0.78
Selective heterologous regulation of 5-HT1A receptor-stimulated 35S GTPgammaS binding in the anterior cingulate cortex as a result of 5-HT2 receptor activation. Brain Res (2002) 0.77
Retrial of selective serotonin reuptake inhibitors in children with pervasive developmental disorders: a retrospective chart review. J Child Adolesc Psychopharmacol (2009) 0.77
Buspirone for autistic disorder in a woman with an intellectual disability. Ann Pharmacother (2007) 0.76
Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res (2006) 2.62
Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron (2006) 2.00
Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol (2007) 1.48
Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci U S A (2012) 1.48
Deficits in dopamine clearance and locomotion in hypoinsulinemic rats unmask novel modulation of dopamine transporters by amphetamine. J Neurochem (2005) 1.34
Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression. J Neurosci (2013) 1.29
Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc Natl Acad Sci U S A (2008) 1.29
Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis. J Neurosci (2010) 1.25
Chronic intermittent cold stress and serotonin depletion induce deficits of reversal learning in an attentional set-shifting test in rats. Psychopharmacology (Berl) (2008) 1.24
Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology (2010) 1.22
Ethanol-related behaviors in serotonin transporter knockout mice. Alcohol Clin Exp Res (2006) 1.18
Feeding conditions differentially affect the neurochemical and behavioral effects of dopaminergic drugs in male rats. Eur J Pharmacol (2008) 1.18
Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. PLoS Biol (2010) 1.16
Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse (2008) 1.13
Zebrafish Behavior in Novel Environments: Effects of Acute Exposure to Anxiolytic Compounds and Choice of Danio rerio Line. Int J Comp Psychol (2010) 1.12
Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice. J Neurochem (2003) 1.07
Brain cannabinoid CB2 receptor in schizophrenia. Biol Psychiatry (2009) 1.07
You are what you eat: influence of type and amount of food consumed on central dopamine systems and the behavioral effects of direct- and indirect-acting dopamine receptor agonists. Neuropharmacology (2012) 1.04
Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter. Proc Natl Acad Sci U S A (2011) 1.03
Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun. J Neurosci (2010) 1.02
Impaired striatal Akt signaling disrupts dopamine homeostasis and increases feeding. PLoS One (2011) 1.01
Effect of early rearing conditions on alcohol drinking and 5-HT1A receptor function in C57BL/6J mice. Int J Neuropsychopharmacol (2006) 1.00
Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha 2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304). J Pharmacol Exp Ther (2003) 1.00
Reduced BDNF attenuates inflammation and angiogenesis to improve survival and cardiac function following myocardial infarction in mice. Am J Physiol Heart Circ Physiol (2013) 0.97
Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats. Int J Neuropsychopharmacol (2009) 0.97
Rapid stimulation of presynaptic serotonin transport by A(3) adenosine receptors. J Pharmacol Exp Ther (2007) 0.97
Fluoxetine disrupts food intake and estrous cyclicity in Fischer female rats. Brain Res (2006) 0.96
CB1-independent inhibition of dopamine transporter activity by cannabinoids in mouse dorsal striatum. J Neurochem (2007) 0.95
Plasticity of presynaptic and postsynaptic serotonin 1A receptors in an animal model of epilepsy-associated depression. Neuropsychopharmacology (2011) 0.91
Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry. Neurochem Int (2005) 0.91
Mechanisms of ligand-induced desensitization of the 5-hydroxytryptamine(2A) receptor. J Pharmacol Exp Ther (2002) 0.91
Gender differences in the enhanced vulnerability of BDNF+/- mice to mild stress. Int J Neuropsychopharmacol (2009) 0.90
Rescue of dopamine transporter function in hypoinsulinemic rats by a D2 receptor-ERK-dependent mechanism. J Neurosci (2012) 0.88
Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.87
Evidence for D2 receptor mediation of amphetamine-induced normalization of locomotion and dopamine transporter function in hypoinsulinemic rats. J Neurochem (2007) 0.87
Insulin regulation of monoamine signaling: pathway to obesity. Neuropsychopharmacology (2011) 0.87
Sensitivity of hippocampal 5-HT1A receptors to mild stress in BDNF-deficient mice. Int J Neuropsychopharmacol (2012) 0.87
Association study between alcoholism and endocannabinoid metabolic enzyme genes encoding fatty acid amide hydrolase and monoglyceride lipase in a Japanese population. Psychiatr Genet (2007) 0.86
Neuronal cytoskeleton and synaptic densities are altered after a chronic treatment with the cannabinoid receptor agonist WIN 55,212-2. Brain Res (2006) 0.86
Chronic administration of venlafaxine fails to attenuate 5-HT1A receptor function at the level of receptor-G protein interaction. Int J Neuropsychopharmacol (2005) 0.86
Inhibition of dopamine transporter activity by G protein βγ subunits. PLoS One (2013) 0.86
Antidepressant-like drug effects in juvenile and adolescent mice in the tail suspension test: Relationship with hippocampal serotonin and norepinephrine transporter expression and function. Front Pharmacol (2013) 0.85
Serotonin-1A receptor function in the dorsal raphe nucleus following chronic administration of the selective serotonin reuptake inhibitor sertraline. J Neurochem (2007) 0.85
Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release. J Biol Chem (2013) 0.85
GABAB receptor-positive modulators: brain region-dependent effects. J Pharmacol Exp Ther (2011) 0.85
Interleukin-1β causes fluoxetine resistance in an animal model of epilepsy-associated depression. Neurotherapeutics (2012) 0.84
Distribution of CB2 cannabinoid receptor in adult rat retina. Synapse (2010) 0.84
Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment. J Neurochem (2004) 0.84
Behavioral methods in cannabinoid research. Methods Mol Med (2006) 0.84
Serotonin (5-HT) transporter (SERT) function after graded destruction of serotonergic neurons. J Neurochem (2003) 0.82
Catecholamine/Serotonin interactions: systems thinking for brain function and disease. Adv Pharmacol (2013) 0.82
Functional polymorphism in the GPR55 gene is associated with anorexia nervosa. Synapse (2011) 0.82
Behavioral effects of amphetamine in streptozotocin-treated rats. Eur J Pharmacol (2007) 0.82
Reduced effectiveness of escitalopram in the forced swimming test is associated with increased serotonin clearance rate in food-restricted rats. Int J Neuropsychopharmacol (2009) 0.82
Juxtacellular labeling and chemical phenotyping of extracellularly recorded neurons in vivo. Methods Mol Biol (2006) 0.81
Enhanced novelty-induced corticosterone spike and upregulated serotonin 5-HT1A and cannabinoid CB1 receptors in adolescent BTBR mice. Psychoneuroendocrinology (2013) 0.80
NrCAM-regulating neural systems and addiction-related behaviors. Addict Biol (2012) 0.80
The discovery of a new structural class of cyclin-dependent kinase inhibitors, aminoimidazo[1,2-a]pyridines. Mol Cancer Ther (2004) 0.80
Differential in vivo clearance of serotonin in rat dorsal raphe nucleus and CA3 region. Brain Res (2002) 0.79
Differential regulation of serotonin-1A receptor-stimulated [35S]GTP gamma S binding in the dorsal raphe nucleus by citalopram and escitalopram. Eur J Pharmacol (2008) 0.78
Molecular neurobiological methods in marijuana-cannabinoid research. Methods Mol Med (2006) 0.78
Aging alters in a region-specific manner serotonin transporter sites and 5-HT(1A) receptor-G protein interactions in hamster brain. Neuropharmacology (2002) 0.78
Morphometric study on cytoskeletal components of neuronal and astroglial cells after chronic CB1 agonist treatment. Methods Mol Med (2006) 0.77
Prenatal cocaine exposure alters maternal retrieval behavior in mice. Behav Genet (2002) 0.77
Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine. Eur J Pharmacol (2006) 0.76
Endocannabinoid system, pharmacogenomics and response to therapy. Pharmacogenomics (2010) 0.76
Comment on "preclinical models: status of basic research in depression". Biol Psychiatry (2003) 0.75
What's old is new. ACS Chem Neurosci (2013) 0.75
Ethanol effects on multiple fixed-interval, fixed-ratio responding in mice with deletions of the serotonin transporter gene. Behav Pharmacol (2014) 0.75
Biphasic effects of selective serotonin reuptake inhibitors on anxiety: rapid reversal of escitalopram's anxiogenic effects in the novelty-induced hypophagia test in mice? Behav Pharmacol (2017) 0.75
Disruption of agonist and ligand activity in an AMPA glutamate receptor splice-variable domain deletion mutant. Brain Res (2008) 0.75